title: Proceedings of the AMCP Partnership Forum: Breaking the Link Between Pain Management and Opioid Use Disorder.
abstract: Prescription drug misuse and abuse, especially with opioid analgesics, is the fastest growing drug problem in the United States. Addressing this public health crisis demands the coordinated efforts and actions of all stakeholders to establish a process of improving patient care and decreasing misuse and abuse. On September 9, 2014, the Academy of Managed Care Pharmacy (AMCP) convened a meeting of multiple stakeholders to recommend activities and programs that AMCP can promote to improve pain management, prevent opioid use disorder (OUD), and improve medication-assisted treatment outcomes. The speakers and panelists recommended that efforts to improve pain management outcomes and reduce the potential for OUD should rely on demonstrated evidence and best practices. It was recommended that AMCP promote a more holistic and evidence-based approach to pain management and OUD treatment that actively engages the patient in the decision-making process and includes care coordination with medical, pharmacy, behavioral, and mental health aspects of organizations, all of which is seamlessly supported by a technology infrastructure. To accomplish this, it was recommended that AMCP work to collaborate with organizations representing these stakeholders. Additionally, it was recommended that AMCP conduct continuing pharmacy education programs, develop a best practices toolkit on pain management, and actively promote quality standards for OUD prevention and treatment.
mesh_terms: D000701:Analgesics, Opioid / Q000009:adverse effects / Q000627:therapeutic use*; D019033:Delivery of Health Care, Integrated; D004513:Education, Pharmacy, Continuing; D006801:Humans; D033183:Interdisciplinary Communication; D009293:Opioid-Related Disorders / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*; D010146:Pain / Q000175:diagnosis / Q000517:prevention & control*; D059408:Pain Management / Q000009:adverse effects / Q000379:methods* / Q000592:standards; D010595:Pharmacists; D063487:Prescription Drug Misuse / Q000517:prevention & control*; D024382:Professional Role; D058996:Quality Improvement; D019984:Quality Indicators, Health Care; D012307:Risk Factors
chemical_list: D000701:Analgesics, Opioid